Current Assets
Available For Sale Securities Debt Securities Current
Biogen Available For Sale Securities Debt Securities Current increased by 11.5% to $900.00M in Q1 2026 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Available For Sale Securities Debt Securities Current shows a downward trend with a -8.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
Detailed definition
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Peer comparison
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
Metric ID:
current_assets_available_for_sale_securities_debt_securi_87ec82Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.31B | $1.41B | $1.54B | $2.00B | $2.15B | $1.24B | $1.47B | $2.14B | $3.46B | $0.00 | $0.00 | $0.00 | $97.60M | $807.20M | $900.00M |
| QoQ Change | — | +8.0% | +9.0% | +29.9% | +7.4% | -42.6% | +19.3% | +45.4% | +61.5% | -100.0% | — | — | — | +727.0% | +11.5% |
| YoY Change | — | — | — | — | +64.4% | -12.6% | -4.4% | +7.0% | +60.9% | -100.0% | -100.0% | — | — | — | — |
Range$0.00 – $3.46B
CAGR-10.1%
Avg YoY Growth-12.1%
Median YoY Growth-4.4%
Current Streak2+ quarters growth
Available For Sale Securities Debt Securities Current at Other Companies
Frequently Asked Questions
- What is Biogen's available for sale securities debt securities current?
- Biogen (BIIB) reported available for sale securities debt securities current of $900.00M in Q1 2026.
- What is the long-term trend for Biogen's available for sale securities debt securities current?
- Over 5 years (2020 to 2025), Biogen's available for sale securities debt securities current has grown at a -8.8% compound annual growth rate (CAGR), from $1.28B to $807.20M.
- What does available for sale securities debt securities current mean?
- Short-term investments in debt securities that the company intends to sell within a year.